LOS ANGELES TIMES (LT) - MONDAY May 16, 1988
Robert Steinbrook; Times Medical Writer
The situation is called "latency." It was a key topic of discussion last week at an AIDS meeting sponsored by Abbott Laboratories.
In a latent viral infection, viral genes become incorporated into the genes of infected cells, but no viral particles are produced. As a result, an infected person would not produce antibody molecules in response to the multiplying virus.
But after a period of time--perhaps months or years--the virus begins to reproduce and antibody molecules are made.
While latency is of great scientific interest as a means of better understanding the AIDS virus, its practical significance is not clear.
So far, the situation has apparently been observed with the AIDS virus in several French hemophiliacs studied by Dr. Luke Montagnier of the Pasteur Institute in Paris and two homosexuals being studied in Frankfurt, West Germany. Their latent AIDS virus infections have lasted two years or more, compared to the approximately one year of latency that had been detected in earlier studies.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, cautioned that researchers will need "to learn from experience" how long the latency period is and how frequently the apparently rare situation occurs. Another unanswered question is whether the virus can be transmitted during the latent phase of infection.
New blood tests that can detect viral genes in the absence of viral particles or antibodies are under development. When they become widely available, "people in high-risk groups may wish to have their blood checked for latent infection," Fauci said.
Latent AIDS virus infections are not expected to affect the safety of the blood supply. This is because individuals in AIDS high-risk groups are already ineligible to donate blood, even if they test negative for AIDS antibodies.
In another development, scientists may soon have a better means of distinguishing the original human immunodeficiency virus, known as HIV-1, from a variant AIDS virus, known as HIV-2.
According to Flossie Wong-Staal of the National Cancer Institute, a recently discovered protein is unique to HIV-2 and not found in HIV-1. The discovery should lead to the development of blood tests that can reliably distinguish between the two viruses.
HIV-2 was originally detected in West Africa. But now infected individuals have been found in other parts of Africa and Western Europe.
Copyright © 1988 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. http://www.latimes.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .